Repository logo
 

The structure of EXTL3 helps to explain the different roles of bi-domain exostosins in heparan sulfate synthesis

Published version
Peer-reviewed

Change log

Authors

Wilson, LFL 
Dendooven, T 
Hardwick, SW 
Echevarría-Poza, A 
Tryfona, T 

Abstract

Abstract: Heparan sulfate is a highly modified O-linked glycan that performs diverse physiological roles in animal tissues. Though quickly modified, it is initially synthesised as a polysaccharide of alternating β-d-glucuronosyl and N-acetyl-α-d-glucosaminyl residues by exostosins. These enzymes generally possess two glycosyltransferase domains (GT47 and GT64)—each thought to add one type of monosaccharide unit to the backbone. Although previous structures of murine exostosin-like 2 (EXTL2) provide insight into the GT64 domain, the rest of the bi-domain architecture is yet to be characterised; hence, how the two domains co-operate is unknown. Here, we report the structure of human exostosin-like 3 (EXTL3) in apo and UDP-bound forms. We explain the ineffectiveness of EXTL3’s GT47 domain to transfer β-d-glucuronosyl units, and we observe that, in general, the bi-domain architecture would preclude a processive mechanism of backbone extension. We therefore propose that heparan sulfate backbone polymerisation occurs by a simple dissociative mechanism.

Description

Funder: University of Cambridge; doi: https://doi.org/10.13039/501100000735


Funder: AstraZeneca; doi: https://doi.org/10.13039/100004325


Funder: RCUK | Biotechnology and Biological Sciences Research Council (BBSRC); doi: https://doi.org/10.13039/501100000268


Funder: RCUK | Engineering and Physical Sciences Research Council (EPSRC); doi: https://doi.org/10.13039/501100000266


Funder: OpenPlant, BB/L014130/1

Keywords

Article, /631/45/221, /631/535/1258/1259, /631/45/607, /631/45/173, /13/106, /13/109, /82/29, /82/80, /82/83, /82/58, /101/28, article

Journal Title

Nature Communications

Conference Name

Journal ISSN

2041-1723

Volume Title

13

Publisher

Nature Publishing Group UK
Sponsorship
Wellcome Trust (Wellcome) (200873/Z/16/Z)
Vetenskapsrådet (Swedish Research Council) (2016-04855, 2014-03402)
Cancerfonden (Swedish Cancer Society) (21 1426 Pj 01 H)